| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 41.920 | 49.743 | 56.250 | 44.479 | - | 46.864 | 45.054 | 49.038 | 49.227 | 0 |
| Total Income - EUR | 42.669 | 50.292 | 56.250 | 44.479 | - | 46.864 | 45.083 | 49.038 | 49.575 | 0 |
| Total Expenses - EUR | 14.251 | 13.844 | 15.534 | 17.888 | - | 19.610 | 20.228 | 22.040 | 23.455 | 2.222 |
| Gross Profit/Loss - EUR | 28.418 | 36.449 | 40.715 | 26.591 | - | 27.254 | 24.855 | 26.998 | 26.120 | -2.222 |
| Net Profit/Loss - EUR | 27.151 | 35.951 | 40.153 | 26.146 | - | 26.819 | 24.454 | 26.571 | 25.684 | -2.222 |
| Employees | 4 | 3 | 3 | 3 | - | 3 | 3 | 3 | 3 | 0 |
Check the financial reports for the company - Dexyl Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 7.657 | 7.517 | 7.329 | 7.134 | - | 6.849 | 6.697 | 6.718 | 6.698 | 21.778 |
| Current Assets | 129.712 | 164.309 | 201.948 | 225.284 | - | 143.727 | 164.971 | 115.091 | 135.909 | 13.625 |
| Inventories | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | 112 | 111 | 109 | 107 | - | 103 | 101 | 266 | 594 | 607 |
| Cash | 129.600 | 164.198 | 201.839 | 225.177 | - | 143.623 | 164.870 | 114.825 | 135.314 | 13.018 |
| Shareholders Funds | 136.100 | 170.662 | 207.927 | 230.257 | - | 149.037 | 170.186 | 116.174 | 141.505 | 25.110 |
| Social Capital | 45 | 45 | 44 | 43 | - | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.270 | 1.164 | 1.350 | 2.161 | - | 1.539 | 1.483 | 5.635 | 1.101 | 10.293 |
| Income in Advance | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6612 - 6612" | |||||||||
| CAEN Financial Year |
6612
|
|||||||||
Comments - Dexyl Srl